Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...
1d
ScienceAlert on MSNWeight Loss Drug Semaglutide Shows Promise as Alzheimer's TreatmentScientists are trying to tackle Alzheimer's from all angles, and a new study adds to the growing evidence that semaglutide, a ...
A new study links semaglutide, the active ingredient in Ozempic and Wegovy, to a higher risk of hair loss, especially in ...
2d
Study Finds on MSNCan Semaglutide Help Heavy Drinkers Avoid Alcohol?For years, people taking GLP-1 type drugs (e.g., Ozempic, Wegovy) have noticed that the medicines didn’t just help them to ...
Hypera plans to introduce a generic version of semaglutide in Brazil following patent expiration in 2026. The company is optimistic about market growth despite potential price impacts. Analysts ...
2d
HealthDay on MSNTirzepatide, Semaglutide Not Cost-Effective at Current PricesTirzepatide and semaglutide offer long-term health benefits but are not cost-effective, according to a study publi ...
Last month, the U.S. Food and Drug Administration (the “FDA”) announced in a Declaratory Order the resolution of the shortage of semaglutide ...
By Alberto Alerigi SAO PAULO (Reuters) -Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide ...
Hims & Hers Health, Inc. stock faces volatility after an FDA halt on its GLP-1 drug. Click here to find out why HIMS stock is ...
The use of GLP-1 receptor agonists, like semaglutide, to treat type 2 diabetes is not associated with an increased risk of ...
While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...
While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results